ÌÇÐÄvlog´«Ã½

Japan Continuous Glucose Monitoring Devices Market Analysis

The Japan Continuous Glucose Monitoring Devices Market size is estimated at USD 96.12 million in 2024, and is expected to reach USD 186.25 million by 2029, growing at a CAGR of 10.99% during the forecast period (2024-2029).

COVID-19 disrupted all aspects of the diabetes industry worldwide and in Japan. Several companies faced disruptions in supply and distribution channels nationwide since most of the CGM device components were manufactured outside of Japan. This created a gap between the supply and demand of the devices wherein the limited inventory was available. As a result, the impact of COVID-19 was considerable concerning access to a persistent continuum of care among the Japanese diabetic population. For instance, as per the primary insights, "Almost all Japanese diabetes patients visited their hospital or clinic every 2-3 months despite the COVID-19 pandemic. However, HCPs had limited communication with their patients, which impacted the consumer base and made it difficult to gain new users. In addition, the companies dealing in diabetes care were shut down, and patients visiting hospitals/clinics were unable to provide the product's information to HCPs" (Registered Nurse, Diabetes Care Japan, Lifescan).

Diabetes is a chronic condition marked by high blood glucose levels. It is caused either by the inability to produce insulin (a hormone made by the pancreas to keep blood glucose levels in range) or by the body not being able to use insulin effectively, or both.

Type 1 diabetic patients need to take insulin throughout their lives and maintain a healthy diet and regular physical exercise. Whereas Type 2 diabetic patients need to eat healthily, be physically active, and test their blood glucose level, and may also need to take oral medication and insulin to control the glucose level in their blood. The need for monitoring blood glucose levels is on the rise among diabetic patients, mainly to avoid complications, such as cardiovascular diseases, stroke, blood disorders, blindness, and kidney disorder, among others.

Various CGM devices are available in the japan market. Dexcom develops and manufactures the current-generation G6 CGM. Terumo markets the G6 in Japan. The Dexcom G6 system features a wearable sensor attached to a user's abdomen. It automatically transmits glucose measurements every five minutes to a monitor or smart device with a dedicated application. Users can check their real-time glucose values and trends through a visualized graph. Additionally, G6 notifies users when glucose measurements fall outside a pre-set target range. It also sends alerts upon predictions of hypoglycemia occurring in 20 minutes.

Japan Continuous Glucose Monitoring Devices Market Trends

The Durables Segment is Expected to Witness the Highest Growth Rate Over the Forecast Period

Japan Continuous Glucose Monitoring Devices Industry Segmentation

Continuous glucose monitoring is used to automatically keep an eye on blood sugar levels during the day and at night. At any time, one can rapidly determine their blood sugar level. They can notice trends by looking at their glucose fluctuations over several hours or days. The Japan Continuous Glucose Monitoring Devices Market is Segmented by individual components such as sensors and durables (receivers and transmitters), and by Provinces. The report offers the value (in USD) and volume (in Units) for the above segments.